Skip to search formSkip to main contentSkip to account menu

Inhalant Solution

Known as: Inhalation Solutions, Inhalant Solution [Dose Form], Inhalant Solution Dosage Form 
Liquid medication intended to be inhaled.
National Institutes of Health

Related topics

Related topics

35 relations
Acetylcysteine 200 MG/ML Inhalant SolutionAlbuterol 0.833 MG/ML / Ipratropium Bromide 0.167 MG/ML Inhalant SolutionAztreonam 75 MG/ML Inhalant Solution [Cayston]Aztreonam Inhalant Solution [Cayston]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2016
Highly Cited
2016
A phase 3, multi-center, multinational, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of levofloxacin inhalation solution (APT-1026) in stable cystic fibrosis…
Highly Cited
2013
Highly Cited
2013
Comparison of two treatment regimens for eradication of Pseudomonas aeruginosa infection in children with cystic fibrosis.
Highly Cited
2011
Highly Cited
2011
Aztreonam for inhalation solution (AZLI) in patients with cystic fibrosis, mild lung impairment, and P. aeruginosa.
Highly Cited
2011
Highly Cited
2011
Pharmacokinetics and Safety of MP-376 (Levofloxacin Inhalation Solution) in Cystic Fibrosis Subjects
ABSTRACT The pharmacokinetics and tolerability of nebulized MP-376 (levofloxacin inhalation solution [Aeroquin]) were determined… 
2011
2011
Pseudomonas aeruginosa antibiotic susceptibility during long-term use of aztreonam for inhalation solution (AZLI).
OBJECTIVES Aztreonam for inhalation solution (AZLI) is an inhaled antibiotic for patients with cystic fibrosis (CF) and… 
2009
2009
Efficacy of Aerosol MP-376, a Levofloxacin Inhalation Solution, in Models of Mouse Lung Infection Due to Pseudomonas aeruginosa
ABSTRACT Progressive respiratory failure due to Pseudomonas aeruginosa is the leading cause of morbidity and mortality in… 
Highly Cited
2008
Highly Cited
2008
Concomitant treatment with nebulized formoterol and tiotropium in subjects with COPD: a placebo-controlled trial.
Highly Cited
2007
Highly Cited
2007
Sublingual progesterone dilutions as bronchodilator in asthmatic females
Purpose : Theophylline has recently been reported to have concurrent anti-inflammatory effects at low therapeutic plasma… 
Highly Cited
2005
Highly Cited
2005
Safety and tolerability of denufosol tetrasodium inhalation solution, a novel P2Y2 receptor agonist: Results of a phase 1/phase 2 multicenter study in mild to moderate cystic fibrosis
Denufosol tetrasodium (INS37217) is a selective P2Y2 agonist that stimulates ciliary beat frequency and Cl− secretion in normal… 
Highly Cited
2004
Highly Cited
2004
Development and pharmacokinetic characterization of pulmonal and intravenous delta-9-tetrahydrocannabinol (THC) in humans.
The aim of the present study was to develop a physiologically compatible inhalation solution of delta-9-tetrahydrocannabinol (THC… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)